Cita APA (7a ed.)
Harper, S., Afonso, D., Watts, K., Doble, B., Eklund, O., Vadgama, S., . . . Taylor, M. (2025). Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL. PharmacoEconomics, 43(11), 1293-1308.
Cita Chicago Style (17a ed.)
Harper, Sam, Daniela Afonso, Karina Watts, Brett Doble, Oskar Eklund, Sachin Vadgama, Julia Thornton Snider, Stephen Palmer, y Matthew Taylor. "Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL." PharmacoEconomics 43, no. 11 (2025): 1293-1308.
Cita MLA (9a ed.)
Harper, Sam, et al. "Evaluating the Role and Policy Implications of Using External Evidence in Survival Extrapolations: A Case Study of Axicabtagene Ciloleucel Therapy for Second-Line DLBCL." PharmacoEconomics, vol. 43, no. 11, 2025, pp. 1293-1308.
Precaución: Estas citas no son 100% exactas.